NCT04417972View on ClinicalTrials.gov

The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis.

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

179

Participants

Timeline

Start Date

July 30, 2020

Primary Completion Date

May 14, 2024

Study Completion Date

May 14, 2024

Conditions

Endometriosis

Interventions

DRUG

SHR7280

treatment

DRUG

Placebo oral tablet

blank control

Trial Locations (1)

Unknown

Peking University Third Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT04417972 - The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometriosis. | Biotech Hunter | Biotech Hunter